HIF1A and cancer: It was reported that among other biological effects exerted in cancer cells, MBM-02 (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl; Tempol) could also inhibit HIF-1/2 activity, leading to cancer cell death [53,54].